Free Access
| Issue |
Med Sci (Paris)
Volume 39, Number 8-9, Août–Septembre 2023
|
|
|---|---|---|
| Page(s) | 599 - 602 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2023091 | |
| Published online | 11 September 2023 | |
- World Health Organization. Global Tuberculosis Report. 2019; https://www.who.int/publications/i/item/9789241565714. [Google Scholar]
- Lee M, Cho SN, Barry CE, et al. Linezolid for XDR-TB–final study outcomes. N Engl J Med 2015 ; 373 : 290–291. [CrossRef] [PubMed] [Google Scholar]
- Conradie F, Everitt D, Crook AM. Treatment of highly drug resistant pulmonary tuberculosis. N Engl J Med 2020; 382 : 2377. [Google Scholar]
- Falzari K, Zhu Z, Pan D, et al. In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005 ; 49 : 1447–1454. [CrossRef] [PubMed] [Google Scholar]
- Zhang J, Lair C, Roubert C, et al. Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents. Cell 2023; 186 : 1013–25. [CrossRef] [PubMed] [Google Scholar]
- Bulkley D, Innis CA, Blaha G, et al. Revisiting the structures of several antibiotics bound to the bacterial ribosome. Proc Natl Acad Sci USA 2010 ; 107 : 17158–17163. [CrossRef] [PubMed] [Google Scholar]
- Andini N, Nash KA. Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. Antimicrob Agents Chemother 2006 ; 50 : 2560–2562. [CrossRef] [PubMed] [Google Scholar]
- Madsen CT, Jakobsen L, Buriankova K, et al. Methyltransferase Erm37 slips on rRNA to confer atypical resistance in Mycobacterium tuberculosis. J Biol Chem 2005 ; 280 : 38942–38947. [CrossRef] [PubMed] [Google Scholar]
- Arenz S, Wilson DN. Blast from the past: reassessing forgotten translation inhibitors, antibiotic selectivity, and resistance mechanisms to aid drug development. Mol Cell 2016 ; 61 : 3–14. [CrossRef] [PubMed] [Google Scholar]
- Dartois V. The path of anti-tuberculosis drugs: from blood to lesions to mycobacteri.al cells. Nat Rev Microbiol 2014 ; 12 : 159–167. [CrossRef] [PubMed] [Google Scholar]
- Tasneen R, Betoudji F, Tyagi S, et al. Contribution of oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in a mouse model of tuberculosis. Antimicrob Agents Chemother 2016 ; 60 : 270–277. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.